TheNewWayLifeSciencesTeamsWork
BiomniLabisalreadybelovedbytensofthousandsofscientistsacrossleadingpharma,biotech,andacademicorganizations.
Trustedbyteamsatglobalbiopharma
life science organizations already use Biomni Lab
faster hypothesis-to-analysis cycles reported by lab teams
scientists use Biomni to run their workflows
HowteamsuseBiomniLab
Fromearlybiologytotheclinic,oneplatformeveryteamcanuse.
Discovery Biology
Build consensus disease signatures across public omics datasets
Cluster and annotate cell types in single-cell atlases
Map spatial transcriptomics onto tissue architecture
Human Genetics
Map GWAS loci to causal genes with fine-mapping and Mendelian randomization
Review tractability, druggability, and tissue-specific safety
Gate candidates on genetic constraint and direction of effect
Medicinal Chemistry
Run large-scale virtual screens and triage the hits
Design molecules generatively with synthesizable routes
Predict ADMET properties and dock against the structure
Protein Sciences and Biologics
Predict protein structure and binding mode
Design de novo binder and antibody candidates in silico
Assess developability, immunogenicity, and humanization
Preclinical Safety and DMPK
Model population PK and exposure-response to inform dose selection
Predict off-target, hERG, and secondary-pharmacology liabilities
Detect adverse-event signals in public pharmacovigilance data
Clinical Development
Analyze real-world outcomes on your EHR and claims data
Run survival analysis and stratify patient risk
Synthesize evidence systematically with meta-analysis
“With patients waiting for new medicines, there is an urgent need to help scientists move faster without compromising scientific rigor. Biomni Lab stood out because our researchers quickly adopted it and saw its potential to accelerate everyday discovery. We look forward to working with Phylo to explore how agentic AI can help bring new medicines to patients faster.”
Seishi Katsumata, Ph.D.
Corporate Officer, Executive VP, Discovery & Research
Ono Pharmaceutical Co., Ltd.
“Biomni Lab is user-friendly for all scientists to automate bioinformatics analyses, generate publication-quality figures, and even compare results with external datasets. At Ginkgo Datapoints, we hope to incorporate Biomni as an everyday tool in our workflows.”
Ayla Ergun
Senior Director of Data Science
Ginkgo Bioworks
“While researching a specific protein’s role in a disease, Biomni didn’t just return accurate references to support my hypothesis; it actually found a paper with data buried in one of its figures that contradicted my hypothesis. It reinterpreted those findings and helped me refine my hypothesis in a way I hadn’t previously considered. That level of critical thinking and analysis is something I haven’t seen in other AI platforms; it truly felt like collaborating with a subject matter expert… [Biomni has] become an essential part of my workflow.”
Ashkan Javaherian, PhD
Neuroscientist
Biotech Executive
“Biomni Lab turned a CRISPR screen workflow that took nearly 20 hours into one I can complete in under 30 minutes—a roughly 40× speedup. More importantly, it made iteration easy enough to explore parameters freely, leading to better-supported hit calls and more confident conclusions. The bottleneck moved from mechanical execution to scientific decision-making.”
Lai Wei
Project Scientist
UCSD
“Biomni Lab has fundamentally changed how I approach data analysis. Instead of spending days or weeks coordinating iterative requests, I can explore datasets, test hypotheses, and generate publication-quality analyses myself. It has already contributed to several grants in preparation, and its clear documentation makes the work easier to understand, reproduce, and build upon.”
Ezequiel Dantas, MD, PhD
Assistant Professor
NYU Langone
“We used Biomni Lab to screen tens of thousands of compounds, generate docking profiles against crystal structures, and identify a shortlist of leads for empirical testing. This would have been extremely difficult without a medicinal chemistry or structural biology collaboration. Biomni has become a staple in our lab, helping us take on work that was previously out of reach.”
Rahul Bhansali, MD
Clinical Instructor / Postdoctoral Fellow
University of Pennsylvania / Children’s Hospital of Philadelphia
“My lab used Biomni Lab to build a preliminary atlas of publicly available transcription factor perturbations and epigenomic measurements. What would have taken one to two weeks became a single day of guiding the agent. That early atlas gave us the proof of feasibility we needed to take the project forward.”
Sahin Naqvi, PhD
Assistant Professor / PI
Boston Children’s Hospital & Harvard Medical School
DesignedforEnterpriseTrust
Scientifically valid
Clarifies what you're asking before starting, checks its reasoning against a biology knowledge graph, and reviews its own work with traceable references before handing it to you.Read more about our benchmarking
Reproducible
100+ pre-built agentic workflows across the biopharma value chain, with deterministic pipelines for fully reproducible results.
Model-agnostic
Use the best-performing models across a wide range of scientific research tasks while keeping costs in check.
Private by design
Your data stays within your own secure enterprise boundaries, and can be deployed into your own VPC—never used to train models.

